Utility of B-natriuretic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunction
- 1 September 2001
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 111 (4) , 274-279
- https://doi.org/10.1016/s0002-9343(01)00841-5
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care settingJournal of the American College of Cardiology, 2001
- Use of echocardiography in the management of congestive heart failure in the communityJournal of the American College of Cardiology, 1999
- Plasma N-Terminal Pro–Brain Natriuretic Peptide and AdrenomedullinCirculation, 1998
- Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunctionAmerican Heart Journal, 1998
- Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failureJournal of Endocrinological Investigation, 1998
- Evaluation of plasma natriuretic peptides as markers for left ventricular dysfunctionAmerican Heart Journal, 1997
- Attenuation of Compensation of Endogenous Cardiac Natriuretic Peptide System in Chronic Heart FailureCirculation, 1997
- Brain natriuretic peptide predicts mortality in the elderly.Heart, 1997
- Plasma brain natriuretic peptide in assessment of acute dyspnoeaThe Lancet, 1994
- Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure.Circulation, 1993